Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Apr 5;183(6):E309-11.
doi: 10.1503/cmaj.110366. Epub 2011 Mar 21.

Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors

Affiliations
Comment

Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors

Christopher O Phillips. CMAJ. .

Erratum in

  • CMAJ. 2011 Jun 14;183(9):1054
No abstract available

PubMed Disclaimer

Comment on

Similar articles

References

    1. McAlister FA, Zhang J, Tonelli M, et al. The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis. CMAJ 2011;183:655–62 - PMC - PubMed
    1. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431–8 - PubMed
    1. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391–479 - PubMed
    1. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010;16:e1–194 - PubMed
    1. O’Hare AM, Kaufman JS, Covinsky KE, et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II–receptor antagonists in chronic kidney disease: Is the evidence base relevant to older adults? Ann Intern Med 2009;150:717–24 - PubMed

MeSH terms

Substances